The PPARγ Antagonist T 0070907 Suppresses Breast Cancer Cell Proliferation and Motility via Both PPARγ-dependent and-independent Mechanisms

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells.

  2009cited by this paper
• Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells

  2008cited by this paper
• Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

  2008cited by this paper
• FAK expression regulation and therapeutic potential.

  2008cited by this paper
• Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types

  2008cited by this paper
• Inhibition of peroxisome proliferator‐activated receptor γ activity suppresses pancreatic cancer cell motility

  2008cited by this paper
• Modulation of PPAR activity via phosphorylation.

  2007cited by this paper
• PPAR-γ inhibitors as novel tubulin-targeting agents

  2007cited by this paper
• A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.

  2007cited by this paper
• Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.

  2006cited by this paper
• Inhibition of peroxisome proliferator‐activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties

  2006cited by this paper
• The role of focal-adhesion kinase in cancer — a new therapeutic opportunity

  2005cited by this paper
• Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.

  2005cited by this paper
• Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.

  2005cited by this paper
• Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.

  2005cited by this paper
• PPARgamma as a therapeutic target for tumor angiogenesis and metastasis.

  2005cited by this paper
• PPAR gamma signaling exacerbates mammary gland tumor development.

  2004cited by this paper
• FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly

  2004cited by this paper
• The Increased Expression of Peroxisome Proliferator-Activated Receptor-γ1 in Human Breast Cancer Is Mediated by Selective Promoter Usage

  2004cited by this paper
• Peroxisome-proliferator-activated receptors and cancers: complex stories

  2004cited by this paper
• Cell Migration: Integrating Signals from Front to Back

  2003cited by this paper
• T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities*

  2002cited by this paper
• Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma.

  2002cited by this paper
• Loss of the Peroxisome Proliferation-activated Receptor gamma (PPARγ) Does Not Affect Mammary Development and Propensity for Tumor Formation but Leads to Reduced Fertility*

  2002cited by this paper
• Peroxisome proliferator-activated receptor- gamma expression in human malignant and normal brain, breast and prostate-derived cells.

  2001cited by this paper
• Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.

  2000cited by this paper
• PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.

  1999cited by this paper
• Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells

  1999cited by this paper
• Terminal differentiation of human breast cancer through PPAR gamma.

  1998cited by this paper
• Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

  1998cited by this paper
• The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene*

  1997cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• Cancer,Facts and Figures about.

  year unknowncited by this paper

• Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities

  2020cites this paper
• A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis

  2017cites this paper